Sangah Chi
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, Gastroesophageal reflux and treatments, Glioma Diagnosis and Treatment, Inflammatory Bowel Disease, Hepatitis C virus research
Most-Cited Works
- → Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)(2016)155 cited
- → Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study(2022)47 cited
- → Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy(2018)21 cited
- → Baseline Wall Thickness Is Lower in Mucosa‐Healed Segments 1 Year After Infliximab in Pediatric Crohn Disease Patients(2016)13 cited
- → Relationship between obesity and development of erosive reflux disease: A mediation analysis of the role of cardiometabolic risk factors(2017)6 cited
- → A Model for Predicting the Future Risk of Incident Erosive Esophagitis in an Asymptomatic Population Undergoing Regular Check-ups(2016)3 cited
- → Comparison of uric acid elevation between aspirin-ticagrelor and aspirin-clopidogrel during dual antiplatelet therapy(2024)3 cited
- → Newly diagnosed high-risk malignant brain tumors with leptomeningeal dissemination in young children: A final update on Head Start II Regimen A2 intensified with high-dose methotrexate(2007)3 cited
- → A phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer(2016)1 cited
- → 214 (PB202): Dual targeting of DNA damage repair pathway by BET and CDK4/6 inhibitors synergistically inhibits breast cancer(2024)